Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)

NCT02494206 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Upper Extremity Lymphedema

Interventions

DRUG: QBX258

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]